APLS
Apellis Pharmaceuticals, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #913
- Final score
- 22.43
- Years on list
- 3
↘ Down 83 since 2023
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- APLS· Apellis Pharmaceuticals, Inc.
- BRKR· Bruker Corporation
- ROIV· Roivant Sciences Ltd.
Figure 01 · Side-by-side summary
The headline numbers
BRKR
Bruker CorporationPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #876
- Final score
- 25.84
- Years on list
- 6
↘ Down 170 since 2020
ROIV
Roivant Sciences Ltd.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #917
- Final score
- 22.02
- Years on list
- 3
↘ Down 566 since 2023
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | APLS | BRKR | ROIV |
|---|---|---|---|
| Climate Change | 16.3 | 28.5 | 25.3 |
| Employee Relations | 30.6 | 18.1 | 31.5 |
| Environment | 15.2 | 25.6 | 15.0 |
| Stakeholders & Society | 18.2 | 21.9 | 20.6 |
| Human Rights | 23.8 | 34.3 | 4.1 |
| Governance | 26.4 | 27.8 | 26.2 |
| Performance Rating | 48.3 | 36.6 | 32.8 |